Script section containing code for Liveperson Chat Solution

Hoover's - A D&B Company - We Make It Easier
Buy Reports For This Company

BB BIOTECH AG
Schaffhausen Switzerland
  (Swiss: BIO)

btn-overview-2btn-people-1btn-competition-1btn-financials-1

Company Description

BB BIOTECH banks on genetics. The investment firm funds private and public biotechnology companies around the world. BB BIOTECH's portfolio includes significant stakes in about five companies including Actelion and Celgene. The company rounds out its portfolio with smaller stakes in about two dozen companies, keeping its holdings below 10%. BB BIOTECH prefers to invest in well-managed companies that are within two years of bringing a product to market. The company has some CHF 2.2 billion (approximately $2 billion) under management. Founded in 1993, BB BIOTECH was an early investor in Amgen, one of the biggest biotechnology companies in the world.

Vordergasse 3Phone: +41-52-624-08-45
Schaffhausen CH-8200Fax: +41-52-624-60-29Map Map This Company
Switzerland

Try a Full Premium Subscription

Access over 85 million companies
Call (866) 443-3939 or

btn-free-trial

Prepare for your Sales call

Try a Small Business Subscription
Starting $89 per month

btn-subscribe-now

BB BIOTECH AG Rankings

TecDAX

Executives

11 executives listed for BB BIOTECH AG's Schaffhausen, Switzerland location.
Vice ChairmanDavid BaltimoreE-mail
DirectorClive MeanwellE-mail

More BB BIOTECH AG Executives

Financials

Company TypePublic - Swiss: BIO Headquarters
Fiscal Year-EndDecember
Employees5
More BB BIOTECH AG Financials
D&B logoDNBi

Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on BB BIOTECH AG now.

  • Reduce risk.
  • Drive greater profitability.
  • Increase cash flow.
Get a Credit Report Now

Sponsored Links